# Impact of GDMT in Uncontrolled Asthma Patients Receiving MHD Inhaled Corticosteroids + Long-acting β2 Agonist

> **NCT07718724** · NA · RECRUITING · sponsor: **AstraZeneca** · enrollment: 540 (estimated)

## Conditions studied

- Uncontrolled Asthma

## Interventions

- **BEHAVIORAL:** Intervention group

## Key facts

- **NCT ID:** NCT07718724
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-09-05
- **Primary completion:** 2028-04-30
- **Final completion:** 2028-04-30
- **Target enrollment:** 540 (ESTIMATED)
- **Last updated:** 2026-09-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07718724

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07718724, "Impact of GDMT in Uncontrolled Asthma Patients Receiving MHD Inhaled Corticosteroids + Long-acting β2 Agonist". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07718724. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*